This inventor holds 1 USPTO granted patent. Top assignee: Astrazeneca Ab. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Peter Schell: Innovator in Therapeutic Agents
Introduction
Peter Schell is a notable inventor based in Molndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic agents. His work has led to the creation of innovative compounds that hold promise for medical applications.
Latest Patents
Peter Schell holds a patent for "Isoxazol-3(2H)-one analogs as therapeutic agents - or a pharmaceutically suitable salt thereof." This patent represents his commitment to advancing therapeutic solutions and showcases his expertise in medicinal chemistry. He has 1 patent to his name, reflecting his innovative contributions to the industry.
Career Highlights
Peter Schell is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role at AstraZeneca allows him to work on cutting-edge research and development projects that aim to improve patient outcomes. His dedication to innovation is evident in his work and the impact it has on the pharmaceutical landscape.
Collaborations
Throughout his career, Peter has collaborated with talented individuals such as Leifeng Cheng and Daniel Tor Pettersen. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in the field of therapeutics.
Conclusion
Peter Schell is a distinguished inventor whose work in therapeutic agents has the potential to make a significant impact in medicine. His contributions, particularly through his patent and role at AstraZeneca, highlight his commitment to innovation and improving healthcare solutions.